• Latest Posts

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy

Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug

More News! 8 Oct 2018

Cannabinoid Drugs Company Raises $300M in Public Offering


Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II

Signed, Sealed. Will GW Pharma’s Epilepsy Treatment Be a 2018 Blockbuster?

More News! 9 Aug 2017

UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure

More News! 29 Mar 2017

More “FDA Love” for Cannabis Company with Orphan Drug Designation